EP 3049426 B1 20171101 - GLYCOCLUSTERS AND THEIR PHARMACEUTICAL USE AS ANTIBACTERIALS
Title (en)
GLYCOCLUSTERS AND THEIR PHARMACEUTICAL USE AS ANTIBACTERIALS
Title (de)
GLYCOCLUSTER UND DEREN PHARMAZEUTISCHE VERWENDUNG ALS ANTIBAKTERIELLE WIRKSTOFFE
Title (fr)
GLYCOCLUSTERS ET LEUR UTILISATION PHARMACEUTIQUE COMME ANTIBACTÉRIENS
Publication
Application
Priority
- EP 13306296 A 20130923
- FR 1452355 A 20140321
- EP 2014070110 W 20140922
- EP 14771331 A 20140922
Abstract (en)
[origin: EP2851371A1] A molecule responding to formula (I) of the glycocluster type with galactose residues at their extremities. Simple and efficient methods for the preparation of these compounds. Medical use of compounds (I) as inhibitors of infections by Pseudomonas aeruginosa, more specifically as inhibitors of Pseudomonas aeruginosa's virulence.
IPC 8 full level
A61K 31/7056 (2006.01); A61P 31/04 (2006.01); C07H 15/26 (2006.01)
CPC (source: EP US)
A61K 9/0073 (2013.01 - US); A61K 31/70 (2013.01 - EP US); A61K 31/7052 (2013.01 - EP US); A61K 31/7056 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 31/04 (2017.12 - EP); C07H 15/26 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 2851371 A1 20150325; CA 2925028 A1 20150326; EP 3049426 A1 20160803; EP 3049426 B1 20171101; ES 2656004 T3 20180222; FR 3010999 A1 20150327; FR 3010999 B1 20170616; JP 2016533342 A 20161027; JP 6595460 B2 20191023; US 10105380 B2 20181023; US 2016287620 A1 20161006; WO 2015040209 A1 20150326
DOCDB simple family (application)
EP 13306296 A 20130923; CA 2925028 A 20140922; EP 14771331 A 20140922; EP 2014070110 W 20140922; ES 14771331 T 20140922; FR 1452355 A 20140321; JP 2016517519 A 20140922; US 201415023470 A 20140922